Perigon Wealth Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-49,321
Closed -$254K 1311
2025
Q3
$343K Buy
49,321
+11,455
+30% +$80.8K 0.01% 892
2025
Q2
$224K Buy
37,866
+4,270
+13% +$24.6K 0.01% 955
2025
Q1
$215K Sell
33,596
-855
-2% -$8.24K 0.01% 939
2024
Q4
$433K Buy
34,451
+13,796
+67% +$235K 0.01% 681
2024
Q3
$572K Buy
20,655
+11,889
+136% +$297K 0.02% 575
2024
Q2
$209K Buy
+8,766
New +$206K 0.01% 802

Other funds holding ASPN

Perigon Wealth Management's ASPN Position: Q4 2025 in Review

Perigon Wealth Management sold out of Aspen Aerogels (ASPN) in Q4 2025, closing a stake of 49,321 shares — an estimated $254K sold.

Perigon Wealth Management first reported a position in ASPN in Q2 2024 and held it in 6 quarters. The position peaked at $572K in Q3 2024. 183 funds tracked by Wall St. Rank hold ASPN as of Q4 2025.

  • Perigon Wealth Management reported no remaining Aspen Aerogels position as of Q4 2025 after selling out during the quarter.
  • Perigon Wealth Management sold 49,321 Aspen Aerogels shares in Q4 2025, an estimated $254K.
  • Perigon Wealth Management first reported a position in Aspen Aerogels in Q2 2024 and held it in 6 quarters.
  • Perigon Wealth Management's Aspen Aerogels position peaked at $572K in Q3 2024.
  • 183 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2025.

Based on Perigon Wealth Management's 13F filing for Q4 2025, filed 16 Jan 2026.